India · Delayed Price · Currency is INR Evoq Remedies Statistics
Total Valuation
Evoq Remedies has a market cap or net worth of INR 79.93 million. The enterprise value is 80.61 million.
| Market Cap | 79.93M |
| Enterprise Value | 80.61M |
Important Dates
The last earnings date was Wednesday, May 27, 2026.
| Earnings Date | May 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Evoq Remedies has 24.90 million shares outstanding. The number of shares has decreased by -3.66% in one year.
| Current Share Class | 24.90M |
| Shares Outstanding | 24.90M |
| Shares Change (YoY) | -3.66% |
| Shares Change (QoQ) | +9.44% |
| Owned by Insiders (%) | 48.21% |
| Owned by Institutions (%) | n/a |
| Float | 12.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| PB Ratio | 0.18 |
| P/TBV Ratio | 0.18 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -33.60 |
| EV / Sales | 0.30 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.77, with a Debt / Equity ratio of 0.00.
| Current Ratio | 6.77 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -0.54% and return on invested capital (ROIC) is -0.57%.
| Return on Equity (ROE) | -0.54% |
| Return on Assets (ROA) | -0.31% |
| Return on Invested Capital (ROIC) | -0.57% |
| Return on Capital Employed (ROCE) | -0.57% |
| Weighted Average Cost of Capital (WACC) | 11.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.52 |
| Inventory Turnover | 13.10 |
Taxes
| Income Tax | -111,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.54% in the last 52 weeks. The beta is 1.42, so Evoq Remedies's price volatility has been higher than the market average.
| Beta (5Y) | 1.42 |
| 52-Week Price Change | -20.54% |
| 50-Day Moving Average | 3.21 |
| 200-Day Moving Average | 3.55 |
| Relative Strength Index (RSI) | 45.56 |
| Average Volume (20 Days) | 34,600 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Evoq Remedies had revenue of INR 267.57 million and -2.40 million in losses. Loss per share was -0.10.
| Revenue | 267.57M |
| Gross Profit | 12.82M |
| Operating Income | -2.51M |
| Pretax Income | -2.51M |
| Net Income | -2.40M |
| EBITDA | -2.00M |
| EBIT | -2.51M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 52,000 in cash and 730,000 in debt, with a net cash position of -678,000 or -0.03 per share.
| Cash & Cash Equivalents | 52,000 |
| Total Debt | 730,000 |
| Net Cash | -678,000 |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | 442.96M |
| Book Value Per Share | 21.27 |
| Working Capital | 441.24M |
Cash Flow
| Operating Cash Flow | -2.82M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 511,000 |
| Net Borrowing | 730,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 4.79%, with operating and profit margins of -0.94% and -0.90%.
| Gross Margin | 4.79% |
| Operating Margin | -0.94% |
| Pretax Margin | -0.94% |
| Profit Margin | -0.90% |
| EBITDA Margin | -0.75% |
| EBIT Margin | -0.94% |
| FCF Margin | n/a |
Dividends & Yields
Evoq Remedies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 3.66% |
| Shareholder Yield | 3.66% |
| Earnings Yield | -3.00% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |